REDWOOD CITY, Calif., Jan. 8 AcelRx Pharmaceuticals, Inc.announced today it has hired Dr. Roman Skowronski as Vice President, ClinicalDevelopment. In this new position, Dr. Skowronski will be responsible fordevelopment and execution of clinical protocols and providing medical inputand review of clinical development strategy. He will report to Dr. PamelaPalmer, the company's Chief Medical Officer.
Prior to joining AcelRx Pharmaceuticals, Dr. Skowronski was Director ofClinical Development at ALZA Corporation, a Johnson & Johnson Company. He hasalso held clinical research and development positions at AlexzaPharmaceuticals and Stanford University School of Medicine.
"We are extremely pleased to have recruited a candidate of Roman'scaliber," stated Pamela Palmer, MD, PhD. "He brings a wealth of knowledge andexperience in the management of analgesic drug development programs as well asdrug-device combination products."
AcelRx Pharmaceuticals, Inc. is an emerging specialty pharmaceuticalcompany focused on the treatment of intermittent and acute medical conditions,with an initial emphasis on pain management.
SOURCE AcelRx Pharmaceuticals, Inc.